EXTON, PA -- (Marketwired) -- 12/22/14 --
In the news release issued Friday, December 19, 2014 by West Pharmaceutical Services, Inc. (NYSE: WST), we are advised by the company that the originally issued headline was incorrect. Complete corrected text follows.
West Announces Quarterly Dividend
EXTON, PA - December 19, 2014 - West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2015 dividend of $0.11 per share. The dividend will be paid on February 4, 2015 to shareholders of record as of January 21, 2015.
West is by the side of its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliability and safety of their products. Every day, West is leading the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched and growing knowledge base of relevant pharmaceutical product testing, development and packaging. Based in Exton, Pa., West supports its customers from sales, manufacturing, customer support and research and development locations in North and South America, Europe, Asia and Australia. Established in 1923, West's 2013 sales totaling $1.4 billion reflect the daily use of approximately 100 million of its components and devices around the world. www.westpharma.com
West and the diamond logo and By your side for a healthier world™ are registered trademarks or trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
Michael A. Anderson
Vice President and Treasurer
Investors and Financial Media:
Source: West Pharmaceutical Services, Inc.